We are live on ! Find out more
ASBP

Aspire Biopharma
ASBP

13 hedge funds and large institutions have $876K invested in Aspire Biopharma in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

550% more funds holding

Funds holding: 2 → 13 (+11)

0% less ownership

Funds ownership: 0% → 0% (-0%)

84% less capital invested

Capital invested by funds: $5.36M → $876K (-$4.48M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
13
Holders Change
+11
Holders Change %
+550%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$2.98M
2
CA
Crewe Advisors
Utah
+$1.8M
3
OAS
Optivise Advisory Services
Tennessee
+$615K
4
PA
Procyon Advisors
Connecticut
+$567K
5
PC
Periscope Capital
Ontario, Canada
+$436K

Top Sellers

Rank Fund Capital Flow
1
HCI
Harraden Circle Investments
New York
-$1.73M
2
CS
Clear Street
New York
-$183K
Name Holding Trade Value Shares
Change 		Change in
Stake
Toronto Dominion Bank
1
Toronto Dominion Bank
Ontario, Canada
$350K +$2.98M +431 New
CA
2
Crewe Advisors
Utah
$183K +$1.8M +261 New
HCI
3
Harraden Circle Investments
New York
$87.4K -$1.73M -250 -67%
OAS
4
Optivise Advisory Services
Tennessee
$62K +$615K +89 New
PA
5
Procyon Advisors
Connecticut
$57.4K +$567K +82 New
PC
6
Periscope Capital
Ontario, Canada
$33.8K +$436K +63 New
PTP
7
Platform Technology Partners
New York
$21.9K +$214K +31 New
UBS Group
8
UBS Group
Switzerland
$17.5K +$173K +25 New
TSS
9
Two Sigma Securities
New York
$16K +$159K +23 New
Citadel Advisors
10
Citadel Advisors
Florida
$15.7K +$152K +22 New
Jane Street
11
Jane Street
New York
$12.2K +$124K +18 New
VF
12
Virtu Financial
New York
$10K +$96.8K +14 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$9.34K +$89.9K +13 New
RFA
14
Reyes Financial Architecture
California
$82 – – –
FFA
15
Farther Finance Advisors
California
$12 – – –
CS
16
Clear Street
New York
– -$183K -13 Closed

ASBP Hedge Fund Activity: Q1 2025 in Review

13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma (ASBP) for Q1 2025, worth a combined $876K — down 84% from $5.36M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ASBP positions and 1 closed out — a net gain of 11 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $2.98M. The largest seller was Harraden Circle Investments, cutting an estimated $1.73M.

  • 13 institutional investors held Aspire Biopharma (ASBP) as of Q1 2025, up from 2 in Q4 2024.
  • Funds reported $876K of Aspire Biopharma stock for Q1 2025, down 84% quarter-over-quarter.
  • 12 funds opened new Aspire Biopharma positions in Q1 2025 and 1 closed out, a net change of +11 holders.
  • The largest Aspire Biopharma buyer in Q1 2025 was Toronto Dominion Bank, an estimated $2.98M added.
  • The largest Aspire Biopharma seller in Q1 2025 was Harraden Circle Investments, an estimated $1.73M sold.

Based on aggregated 13F filings for Q1 2025.